Iontophoretic Terbinafine HCL 1.0% Delivery Across Porcine and Human Nails

BackgroundOnychomycosis is a common disease. Topical treatment is usually not effective due to limitation of trans-nail delivery of antifungal drugs. Successful treatment of deep-seated nail infections remains elusive as the delivery of efficacious levels of antifungal drug to the site of action is very difficult.ObjectivesTo evaluate the influence of several parameters including; the effect of low electrical current, incubation time and the presence of electrolyte (NaCl or KCl) on the penetration of terbinafine through the nail plate into the nail bed, using various formulations and concentrations of terbinafine HCl.MethodsIontophoresis was applied across porcine and human nail in vitro to assess its efficiency in enhancing delivery of terbinafine HCl.ResultsIn this study, we have demonstrated that an optimal electrolyte concentration (1% NaCl or KCl) is required for an effective delivery. There is a significant increase in drug delivery into the nail and into the receiving compartment in the presence of 3% DMSO.ConclusionsThis study demonstrates the efficacy of iontophoresis in enhancing the trans-nail delivery of terbinafine. Clinical studies are needed to evaluate the feasibility, efficacy and safety of iontophoresis of terbinafine in onychomycosis in human.

[1]  S. K. Li,et al.  Transungual iontophoretic transport of polar neutral and positively charged model permeants: effects of electrophoresis and electroosmosis. , 2008, Journal of pharmaceutical sciences.

[2]  Ju-Hyun Kim,et al.  A Method to Measure the Amount of Drug Penetrated Across the Nail Plate , 2001, Pharmaceutical Research.

[3]  S. N. Murthy,et al.  Iontophoretic permselective property of human nail. , 2007, Journal of dermatological science.

[4]  Senshang Lin,et al.  Transdermal iontophoresis: impact on skin integrity as evaluated by various methods. , 2008, Critical reviews in therapeutic drug carrier systems.

[5]  Kelly A. Smith,et al.  Chemical method to enhance transungual transport and iontophoresis efficiency. , 2008, International journal of pharmaceutics.

[6]  B. Elewski,et al.  Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. , 1997, Archives of dermatology.

[7]  R. Hay,et al.  A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis , 1987, Clinical and experimental dermatology.

[8]  R. Hay,et al.  Tioconazole nail solution—an open study of its efficacy in onychomycosis , 1985, Clinical and experimental dermatology.

[9]  R. Hay,et al.  Review of antifungal therapy and the severity index for assessing onychomycosis: Part I , 2008, The Journal of dermatological treatment.

[10]  S. N. Murthy,et al.  Trans-ungual iontophoretic delivery of terbinafine. , 2009, Journal of pharmaceutical sciences.

[11]  N. Dixit,et al.  Iontophoresis - an approach for controlled drug delivery: a review. , 2007, Current drug delivery.

[12]  O. Corrigan,et al.  Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin. , 2007, International journal of pharmaceutics.

[13]  J. Garduno,et al.  Review of antifungal therapy, part II: Treatment rationale, including specific patient populations , 2008, The Journal of dermatological treatment.

[14]  G. Petrányi,et al.  Antifungal activity of the allylamine derivative terbinafine in vitro , 1987, Antimicrobial Agents and Chemotherapy.

[15]  H. Trau,et al.  Onychomycosis: rationalization of topical treatment. , 2008, The Israel Medical Association journal : IMAJ.

[16]  D. Wiskirchen,et al.  Iontophoretic drug delivery across human nail. , 2007, Journal of pharmaceutical sciences.

[17]  D. Mehregan,et al.  The cost effectiveness of testing for onychomycosis versus empiric treatment of onychodystrophies with oral antifungal agents. , 1999, Cutis.

[18]  O. Corrigan,et al.  Iontophoretic and chemical enhancement of drug delivery. Part I: across artificial membranes. , 2003, International journal of pharmaceutics.

[19]  Aditya K. Gupta,et al.  Therapies for onychomycosis: a review. , 2006, Dermatologic clinics.

[20]  R. Scher Onychomycosis: therapeutic update. , 1999, Journal of the American Academy of Dermatology.

[21]  N. Ho Professor William I. Higuchi: teacher and scientist. , 2008, Journal of pharmaceutical sciences.

[22]  S. K. Li,et al.  Mechanistic study of electroosmotic transport across hydrated nail plates: effects of pH and ionic strength. , 2008, Journal of pharmaceutical sciences.

[23]  A. Shemer,et al.  Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study , 2010, The British journal of dermatology.

[24]  B. Elewski,et al.  A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. , 2000, Journal of the American Academy of Dermatology.